Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
Rhea-AI Summary
Carlsmed (Nasdaq: CARL) announced that Mike Cordonnier, Chairman and CEO, will present at the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 from 4:30–5:10 PM PT in San Francisco.
Carlsmed management also said it will host one-on-one investor meetings during the conference.
Positive
- None.
Negative
- None.
News Market Reaction – CARL
On the day this news was published, CARL declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed moves: NRC up 1.52%, while OPRX, SPOK, SY, and TALK are down between 0.57% and 5.21%, suggesting stock-specific factors rather than a unified sector trend.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 03 | Product launch | Positive | +12.4% | U.S. launch of aprevo cervical platform with early clinical experience data. |
| Nov 19 | Conference participation | Neutral | -0.2% | Piper Sandler healthcare conference presentation and investor meetings. |
| Nov 06 | Earnings and guidance | Positive | -1.7% | Q3 2025 results with 98% YoY revenue growth and raised guidance. |
| Oct 23 | Earnings scheduling | Neutral | +3.6% | Announcement of upcoming Q3 2025 earnings release and call details. |
| Sep 29 | Executive appointment | Positive | -1.6% | Appointment of a new Chief Legal Officer to support post‑IPO growth. |
Operational and conference updates often saw modest price reactions, while some fundamentally positive events, like raised guidance and leadership additions, previously showed negative next-day moves.
Over the last few months, Carlsmed reported strong Q3 2025 growth with revenue of $13.1M and raised full‑year guidance, alongside expanded debt capacity and balance‑sheet strengthening after its IPO. Product news included the U.S. launch of the aprevo cervical platform, with early clinical experience shared at a major spine meeting. The company also enhanced its leadership team and participated in investor conferences. Today’s J.P. Morgan conference participation fits the pattern of ongoing investor outreach following these commercial and financial milestones.
Market Pulse Summary
This announcement highlights Carlsmed’s participation in the J.P. Morgan 2026 Healthcare Conference, with management presenting and hosting one‑on‑one investor meetings on January 14, 2026. In recent months the company reported strong Q3 2025 revenue of $13.1M, raised full‑year guidance, and launched its aprevo cervical platform in the U.S. Investors may watch how conference visibility complements these operational milestones and how the stock trades relative to its 200-day moving average and 52-week range.
AI-generated analysis. Not financial advice.
CARLSBAD, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed will be presenting at the J.P. Morgan 2026 Healthcare conference on Wednesday, January 14th at 4:30-5:10 pm PT in San Francisco, CA. During the conference, Carlsmed Management will be hosting 1x1 investor meetings.
About Carlsmed, Inc.
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com
Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com
FAQ
When will Carlsmed (CARL) present at the J.P. Morgan 2026 Healthcare Conference?
Who from Carlsmed (CARL) will present at the J.P. Morgan 2026 Healthcare Conference?
Will Carlsmed (CARL) hold investor meetings at the J.P. Morgan 2026 Healthcare Conference?
Where is the J.P. Morgan 2026 Healthcare Conference presentation by Carlsmed (CARL) located?
How long is the Carlsmed (CARL) presentation at the J.P. Morgan 2026 Healthcare Conference?
How can investors request a one-on-one meeting with Carlsmed (CARL) at the conference?
